ID

42565

Description

Pravastatin for Hyperlipidaemia in HIV.; ODM derived from: https://clinicaltrials.gov/show/NCT00227500

Lien

https://clinicaltrials.gov/show/NCT00227500

Mots-clés

  1. 23/05/2016 23/05/2016 -
  2. 02/09/2021 02/09/2021 -
Téléchargé le

2 septembre 2021

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility HIV Infections NCT00227500

Eligibility HIV Infections NCT00227500

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
provide written informed consent to participate in the trial
Description

written informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
hiv-1 sero-positive
Description

HIV-1 sero-positive

Type de données

boolean

Alias
UMLS CUI [1]
C0019704
male/female >18 years age
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
currently receiving hiv protease inhibitor therapy for > 12 weeks and unlikely to require change in existing regimen during the 16 week study period
Description

receiving hiv protease inhibitor therapy

Type de données

boolean

Alias
UMLS CUI [1]
C0162714
fasting cholesterol > 6.5 mmol/l (mean of 2 samples collected > 3 days apart)
Description

fasting cholesterol

Type de données

boolean

Alias
UMLS CUI [1]
C1282513
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any condition which may interfere with ability to comply with study
Description

ability to comply with study

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C0439801
gastrointestinal disorder which may affect drug absorption
Description

gastrointestinal disorder

Type de données

boolean

Alias
UMLS CUI [1,1]
C0017178
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0678745
hypertension or congestive cardiac failure
Description

hypertension or congestive cardiac failure

Type de données

boolean

Alias
UMLS CUI [1]
C0020538
UMLS CUI [2]
C0018802
lactic acidemia (serum lactate level >2.2 mmol/l)
Description

lactic acidemia

Type de données

boolean

Alias
UMLS CUI [1]
C0347959
any serious medical condition which may compromise the patient’s safety, including pancreatitis or hepatitis within past 6 months
Description

serious medical condition

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C1113679
UMLS CUI [1,3]
C0439801
active aids defining conditions
Description

active aids

Type de données

boolean

Alias
UMLS CUI [1]
C0001175
concurrent therapy with any other lipid lowering agents, oral hypoglycaemics, anabolic steroids or insulin
Description

lipid lowering agents oral hypoglycaemics anabolic steroids or insulin

Type de données

boolean

Alias
UMLS CUI [1]
C0003367
UMLS CUI [2]
C0359086
UMLS CUI [3]
C0002845
UMLS CUI [4]
C0021641

Similar models

Eligibility HIV Infections NCT00227500

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
written informed consent
Item
provide written informed consent to participate in the trial
boolean
C0021430 (UMLS CUI [1])
HIV-1 sero-positive
Item
hiv-1 sero-positive
boolean
C0019704 (UMLS CUI [1])
age
Item
male/female >18 years age
boolean
C0001779 (UMLS CUI [1])
receiving hiv protease inhibitor therapy
Item
currently receiving hiv protease inhibitor therapy for > 12 weeks and unlikely to require change in existing regimen during the 16 week study period
boolean
C0162714 (UMLS CUI [1])
fasting cholesterol
Item
fasting cholesterol > 6.5 mmol/l (mean of 2 samples collected > 3 days apart)
boolean
C1282513 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ability to comply with study
Item
any condition which may interfere with ability to comply with study
boolean
C0009488 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
gastrointestinal disorder
Item
gastrointestinal disorder which may affect drug absorption
boolean
C0017178 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0678745 (UMLS CUI [1,3])
hypertension or congestive cardiac failure
Item
hypertension or congestive cardiac failure
boolean
C0020538 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
lactic acidemia
Item
lactic acidemia (serum lactate level >2.2 mmol/l)
boolean
C0347959 (UMLS CUI [1])
serious medical condition
Item
any serious medical condition which may compromise the patient’s safety, including pancreatitis or hepatitis within past 6 months
boolean
C0009488 (UMLS CUI [1,1])
C1113679 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
active aids
Item
active aids defining conditions
boolean
C0001175 (UMLS CUI [1])
lipid lowering agents oral hypoglycaemics anabolic steroids or insulin
Item
concurrent therapy with any other lipid lowering agents, oral hypoglycaemics, anabolic steroids or insulin
boolean
C0003367 (UMLS CUI [1])
C0359086 (UMLS CUI [2])
C0002845 (UMLS CUI [3])
C0021641 (UMLS CUI [4])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial